Mahim Jain, MD, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Travere Therapeutics
    Topic:
    Insurance Database Analysis
    Date added:
    07/15/2024
    Date updated:
    09/09/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    PWN Genomics
    Topic:
    PRS score review
    Date added:
    07/15/2024
    Date updated:
    09/09/2024
    Relationship end date:
    04/01/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Topic:
    Clinical trial site investigator
    Date added:
    09/09/2024
    Date updated:
    09/09/2024
    Relationship end date:
    03/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi
    Topic:
    Clinical trial site investigator
    Date added:
    09/09/2024
    Date updated:
    09/09/2024
    Relationship end date:
    03/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ultragenyx
    Topic:
    Clinical trial site investigator
    Date added:
    09/09/2024
    Date updated:
    09/09/2024
    Relationship end date:
    03/01/2024
Return to NCH PGR | New and Emerging Treatments for Osteogenesis Imperfecta | ABP MOC Part 2 Credit Only